We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTertiary Minerals Regulatory News (TYM)

Share Price Information for Tertiary Minerals (TYM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1025
Bid: 0.10
Ask: 0.105
Change: -0.0025 (-2.38%)
Spread: 0.005 (5.00%)
Open: 0.105
High: 0.105
Low: 0.1025
Prev. Close: 0.105
TYM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-Yearly Report 2017

26 May 2017 15:21

RNS Number : 4254G
Tertiary Minerals PLC
26 May 2017
 

 26 May 2017

 

TERTIARY MINERALS PLC

(the "Company")

 

 

HALF-YEARLY REPORT 2017

 

Tertiary Minerals plc, the AIM-traded company building a strategic position in the fluorspar sector, announces its unaudited interim results for the six months ended 31 March 2017.

 

Operational Highlights

Storuman Fluorspar Project, Sweden:

· Exploitation (Mine) Permit has been referred to the Swedish Mining Inspectorate for re-assessment

· The re-assessment is progressing; the Company has met with the Mining Inspectorate twice in 2017 and information supplementing the original application will be supplied to the Mining Inspectorate in May 2017

· With the continued support from key stakeholders, the Company is hopeful of a positive resolution in 2017

MB Fluorspar Project, Nevada, USA:

· Scoping Study modelling and testwork ongoing

· Scoping Study to be completed following successful completion of the modelling and testwork

Lassedalen Fluorspar Project, Norway:

· Due diligence has commenced for the purchase of land and old mine workings from Hydro

Kaaresselkä and Kiekerömaa Gold Projects, Finland:

· Successful completion of the sale of its gold assets to TSX-V listed Aurion Resources Ltd

· £100,000 initial consideration has been paid by Aurion: £15,000 in cash and £85,000 in Aurion shares (being 83,072 shares)

· Tertiary retain pre-production and production royalty interests in the projects

Acquisition Opportunities:

· A number of projects have been shortlisted which are potentially near-term revenue generating

· More detailed evaluation and due diligence is in progress

Financial Results - Summary:

 

· Operating Loss for the six month period of £156,140 (six months to 31 March 2016: £219,962) comprises:

o Revenue of £134,885; less

o Administration costs of £286,654 (which includes non-cash share based payments of £6,272); and

o Pre-licence and reconnaissance exploration costs totalling £4,371

 

· Total Group Loss of £211,850 is after charging:

o Impairment of available for sale investment of £55,987

o Interest income of £277

 

· 132,720 Ordinary Shares were issued during the reporting period to a non-executive director in lieu of fees at a price of 1.025 pence per share

 

 

Enquiries

 

Tertiary Minerals plc

Patrick Cheetham, Executive Chairman

Richard Clemmey, Managing Director

 

 

 

+44 (0)1625 838 679

SP Angel Corporate Finance LLP

Nominated Adviser & Joint Broker

Ewan Leggat / Lindsay Mair

 

 

+44 (0) 20 3470 0470

Beaufort Securities Ltd

Joint Broker

Elliot Hance

 

+44 (0)20 7382 8300

 

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

Notes to Editors

Tertiary Minerals plc (ticker symbol 'TYM') is an AIM-traded mineral exploration and development company building a significant strategic position in the fluorspar sector. Fluorspar is an essential raw material in the chemical, steel and aluminium industries. Tertiary controls two significant Scandinavian projects (Storuman in Sweden and Lassedalen in Norway) and a large deposit of strategic significance in Nevada, USA (MB Project).

 

CAUTIONARY NOTICE

The news release may contain certain statements and expressions of belief, expectation or opinion which are forward looking statements, and which relate, inter alia, to the Company's proposed strategy, plans and objectives or to the expectations or intentions of the Company's directors. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the control of the Company that could cause the actual performance or achievements of the Company to be materially different from such forward-looking statements. Accordingly, you should not rely on any forward-looking statements and save as required by the AIM Rules for Companies or by law, the Company does not accept any obligation to disseminate any updates or revisions to such forward-looking statements.

 

Chairman's Statement

 

I am pleased to present our Interim Report for the six month period ended 31 March 2017.

 

The Company has made considerable progress in recent years with its 100% owned fluorspar projects, progressing through the development cycle from discovery towards commercial production.

 

A number of key issues have, however, resulted in delays to the development of our most advanced project, Storuman in Sweden. The government has asked the Swedish Mining Inspector to re-assess its grant of our Mining Concession in the light of a Supreme Court decision to overturn the grant of a third party mining company's mining concession in the south of Sweden. This re-assessment, intended to consider the impact of mining in the concession area on a wider surrounding area, is underway and additional submissions are being made by the Company. Whilst this is frustrating, many companies in Sweden are similarly affected.

 

We continue to have the support of the majority of key stakeholders at Storuman, with the notable exception of the Sami reindeer herding community, and remain hopeful of a positive resolution to this in 2017. Any ratification of the grant of the mining concession will, however, be open to appeal and so we are firm in our resolve not to spend any further money on exploration or development of Storuman until the matter is resolved.

 

In Norway, at our Lassedalen Fluorspar Project, we have commenced due diligence work on the purchase from large Norwegian aluminium producer, Hydro, of the land and mineral rights that underlie our government exploration permissions exploration. A forerunner company of Hydro was responsible for mining fluorspar at Lassedalen in World War II and Hydro is a major consumer of fluorspar downstream products. Due to the presence of old mine workings on the property, a programme of environmental baseline sampling is being undertaken as part of the due diligence. Otherwise the project remains on hold pending a review of project priorities.

 

In Nevada, USA, our drilling over the past few years has demonstrated a very large resource of low-grade fluorspar at the MB Project. We are continuing our technical and economic studies which include metallurgical studies aimed at production of acid grade fluorspar and the evaluation of a potential by-product industrial filler grade mica. We have also planned a further drilling programme to test for higher grade fluorite mineralisation in specific target areas. We aim to complete a Scoping Study in 2017.

 

Fluorspar prices in the USA and Europe have remained stable, albeit at low levels, during the first part of 2017. The fluorochemical industry continues to go through a transition stage whereby the fluorine based HFC refrigerant chemicals are being phased out under various global climate change agreements and legislation and being replaced by new zero ozone-depleting and low global warming potential HFO fluorine based chemicals. China has begun to see an improvement in its fluorspar prices during the period, predominantly driven by supply disruptions and improved demand for refrigerants and hydrofluoric acid. Refrigerant demand in the USA has also improved during the period, and this coupled with the US recently imposing anti-dumping duties on China origin refrigerants may result in a more positive outlook for fluorspar prices and demand in the medium-term.

 

Outside of fluorspar, we were pleased to report in March 2017 the closing of the sale of our Kaaresselkä and Kiekerömaa gold projects in Finland to Canadian listed company Aurion Resources Ltd for £100,000 in cash and shares. We would also receive further payments on the definition of Ore Reserves and Mineral Resources and a royalty on production. Our own historical work on the project leads us to believe that such reserves and resources are likely to be defined with further exploration. The Lapland Gold belt is an emerging gold producing province and Aurion Resources has made a number of new high-grade discoveries in the region of the Kaaresselkä Project. We hope to share in Aurion's future success.

 

In January this year we updated the market on our business strategy and, whilst the Company remains committed to its fluorspar business and the development of its fluorspar assets, it has, since then, been reviewing complementary project acquisition opportunities capable of generating revenue and profits in a shorter timescale. It has currently shortlisted a number of projects where more detailed evaluation and due diligence is in progress. 

 

I would like to take this opportunity to thank shareholders for their continuing support and overwhelming approval at the March 2017 General Meeting of the Board's proposal to subdivide the Ordinary Shares to facilitate future fundraising and we look forward to reporting further progress in 2017.

 

 

Patrick L Cheetham

Executive Chairman

 

26 May 2017

 

 

 

Consolidated Income Statement

for the six months to 31 March 2017

 

 

 

Six months

to 31 March

2017

Unaudited

Six months

to 31 March

2016

Unaudited

Twelve months

 to 30 September

2016

Audited

 

£

 

£

 

£

 

 

 

 

 

 

Revenue

134,885

 

84,568

 

190,124

 

 

 

 

 

 

Administration costs

(286,654)

 

(297,169)

 

(558,857)

 

 

 

 

 

 

Pre-licence and other exploration costs

(4,371)

 

(7,361)

 

(25,343)

 

 

 

 

 

 

 

 

 

 

 

 

Operating loss

(156,140)

 

(219,962)

 

(394,076)

 

 

 

 

 

 

Impairment of available for sale investment

(55,987)

 

(81,142)

 

(81,142)

 

 

 

 

 

 

Interest receivable

277

 

968

 

1,712

 

 

 

 

 

 

 

 

 

 

 

 

Loss before income tax

(211,850)

 

(300,136)

 

(473,506)

 

 

 

 

 

 

Income tax

-

 

-

 

-

 

 

 

 

 

 

Loss for the period attributable to equity holders of the parent

 

(211,850)

 

 

(300,136)

 

 

(473,506)

 

 

 

 

 

 

Loss per share - basic and diluted (pence) (note 2)

(0.08)

 

(0.14)

 

(0.20)

 

 

 

 

Consolidated Statement of Comprehensive Income

for the six months to 31 March 2017

 

 

 

 

 

Six months to 31 March

2017

Unaudited

Six months to

31 March

2016

Unaudited

Twelve months to

30 September

2016

Audited

 

£

 

£

 

£

 Loss for the period

 

(211,850)

 

 

(300,136)

 

 

(473,506)

 

Other comprehensive income:

 

 

 

 

 

 

Items that could be reclassified subsequentlyto the Income Statement:

 

 

 

 

 

 Fair value movement on available for sale investment

 

(3,638)

 

 

-

 

 

-

 Foreign exchange translation differences on foreign currency net investments in subsidiaries

 

 

59,852

 

 

 

217,075

 

 

 

466,534

 

 

 

 

 

 

Items that have been reclassified subsequently

to the Income Statement:

 

 

 

 

 

 Fair value movement on available for sale investment

 

(107,104)

 

 

-

 

 

51,117

 Transfer from available for sale investment reserve on impairment of available for sale investment

 

 

 

55,987

 

 

 

-

 

 

 

-

 

 

 

 

 

 

Total comprehensive income/(loss) for the period attributable to equity holders of the parent

 

(206,753)

 

 

(83,061)

 

 

44,145

 

 

 

Consolidated Statement of Financial Position

at 31 March 2017

 

 

As at

31 March

2017

Unaudited

As at

31 March

2016

Unaudited

As at

30 September

2016

Audited

 

£

 

£

 

£

Non-current assets

 

 

 

 

 

Intangible assets

4,497,712

 

4,038,021

 

4,429,261

Property, plant & equipment

6,607

 

13,147

 

9,785

Available for sale investments

231,463

 

153,353

 

204,470

 

 

 

 

 

 

 

4,735,782

 

4,204,521

 

4,643,516

 

 

 

 

 

 

Current assets

 

 

 

 

 

Receivables

86,975

 

104,578

 

105,032

Cash and cash equivalents

145,212

 

286,773

 

448,474

 

 

 

 

 

 

 

232,187

 

391,351

 

553,506

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

Trade and other payables

(62,555)

 

(78,501)

 

(92,488)

 

 

 

 

 

 

 Net current assets

 

169,632

 

 

312,850

 

 

461,018

 

 

 

 

 

 

Net assets

4,905,414

 

4,517,371

 

5,104,534

 

 

 

 

 

 

Equity

 

 

 

 

 

Called up share capital

2,670,769

 

2,168,453

 

2,669,442

Share premium account

9,066,769

 

9,116,364

 

9,066,735

Merger reserve

131,096

 

131,096

 

131,096

Share warrant reserve

254,567

 

370,269

 

343,486

Available for sale investment reserve

(3,638)

 

-

 

51,117

Foreign currency reserve

442,206

 

132,895

 

382,354

Accumulated losses

(7,656,355)

 

(7,401,706)

 

(7,539,696)

 

 

 

 

 

 

Equity attributable to the owners of the parent

4,905,414

 

4,517,371

 

5,104,534

 

 

 

 

 

 

 

 

 

 

Consolidated Statement of Changes in Equity

 

 

 

Share

Capital

 

Share

Premium

 Account

 

 

Merger

Reserve

 

Share

Warrant

Reserve

 

Available

for Sale

Reserve

 

Foreign

Currency

Reserve

 

 

Accumulated

Losses

 

 

 

Total

 

£

£

£

£

£

£

£

£

At 30 September 2015

1,878,592

8,812,452

131,096

443,813

-

(84,180)

(7,192,302)

3,989,471

Loss for the period

-

-

-

-

-

-

(218,994)

(218,994)

Impairment of available for sale investment

-

-

-

-

-

-

(81,142)

(81,142)

Exchange differences

-

-

-

-

-

217,075

-

217,075

Total comprehensive loss for the period

-

-

-

-

-

217,075

(300,136)

(83,061)

Share issue

289,861

303,912

-

-

-

-

-

593,773

Share based payments expense

-

-

-

17,188

-

-

-

17,188

Transfer of expired warrants

-

-

-

(90,732)

-

-

90,732

-

At 31 March 2016

2,168,453

9,116,364

131,096

370,269

-

132,895

(7,401,706)

4,517,371

Loss for the period

-

-

-

-

-

-

(173,370)

(173,370)

Change in fair value

-

-

-

-

51,117

-

-

51,117

Exchange differences

-

-

-

-

-

249,459

-

249,459

Total comprehensive loss for the period

-

-

-

-

51,117

249,459

(173,370)

127,206

Share issue

500,989

(49,629)

-

-

-

-

-

451,360

Share based payments expense

-

-

-

8,597

-

-

-

8,597

Transfer of expired warrants

-

-

-

(35,380)

-

-

35,380

-

At 30 September 2016

2,669,442

9,066,735

131,096

343,486

51,117

382,354

(7,539,696)

5,104,534

Loss for the period

-

-

-

-

-

-

(155,863)

(155,863)

Transfer of impairment to income statement

-

-

-

-

55,987

-

(55,987)

-

Change in fair value

-

-

-

-

(110,742)

-

-

(110,742)

Exchange differences

-

-

-

-

-

59,852

-

59,852

Total comprehensive loss for the period

-

-

-

-

(54,755)

59,852

(211,850)

(206,753)

Share issue

1,327

34

-

-

-

-

-

1,361

Share based payments expense

-

-

-

6,272

-

-

-

6,272

Transfer of expired warrants

-

-

-

(95,191)

-

-

95,191

-

At 31 March 2017

2,670,769

9,066,769

131,096

254,567

(3,638)

442,206

(7,656,355)

4,905,414

 

 

 

Consolidated Statement of Cash Flows

for the six months to 31 March 2017

 

 

 

Six months

to 31 March

2017

Unaudited

Six months

to 31 March

2016

Unaudited

Twelve months

to 30 September

2016

Audited

 

£

 

£

 

£

Operating activity

 

 

 

 

 

 

 

 

 

 

 

Total loss after tax

(212,127)

 

(301,104)

 

(475,218)

Depreciation charge

3,265

 

3,471

 

6,833

Shares issued in lieu of net fees

1,361

 

1,361

 

2,721

Impairment charge - available for sale investment

55,987

 

81,142

 

81,142

Share based payment charge

6,272

 

17,188

 

25,784

Non-cash additions to available for sale investment

(52,735)

 

(86,272)

 

(86,272)

(Increase)/decrease in receivables

18,057

 

(14,269)

 

(14,723)

Increase/(decrease) in payables

(29,933)

 

(24,279)

 

(10,292)

 

 

 

 

 

 

 

 

 

 

Net cash outflow from operating activity

(209,853)

 

(322,762)

 

(470,025)

 

 

 

 

 

Investing activity

 

 

 

 

 

 

 

 

 

Interest received

277

 

968

 

1,712

Development expenditures

(108,558)

 

(292,326)

 

(473,527)

Disposal of exploration asset

15,000

 

-

 

-

Purchase of property, plant & equipment

(87)

 

(9,322)

 

(9,322)

 

 

 

 

 

 

 

 

 

 

Net cash outflow from investing activity

(93,368)

 

(300,680)

 

(481,137)

 

 

 

 

 

Financing activity

 

 

 

 

 

 

 

 

 

Issue of share capital (net of expenses)

-

 

592,412

 

1,042,412

 

 

 

 

 

 

 

 

 

 

Net cash inflow from financing activity

-

 

592,412

 

1,042,412

 

 

 

 

 

Net (decrease)/increase in cash and cash

equivalents

 

(303,221)

 

 

(31,030)

 

91,250

 

 

 

 

 

Cash and cash equivalents at start of period

448,474

 

309,815

 

309,815

Exchange differences

(41)

 

7,988

 

47,409

 

 

 

 

 

Cash and cash equivalents at end of period

 

145,212

 

 

286,773

 

448,474

 

 

 

 

 

Notes to the Interim Statement

 

1. Basis of preparation

 

The consolidated interim financial information has been prepared in accordance with the accounting policies that are expected to be adopted in the Group's full financial statements for the year ending 30 September 2017 which are not expected to be significantly different to those set out in Note 1 of the Group's audited financial statements for the year ended 30 September 2016. These are based on the recognition and measurement principles of IFRS in issue as adopted by the European Union (EU) or that are expected to be adopted and effective at 30 September 2017. The financial information has not been prepared (and is not required to be prepared) in accordance with IAS 34. The accounting policies have been applied consistently throughout the Group for the purposes of preparation of this financial information.

 

The financial information in this statement relating to the six months ended 31 March 2017 and the six months ended 31 March 2016 has neither been audited nor reviewed by the Auditors, pursuant to guidance issued by the Auditing Practices Board. The financial information presented for the year ended 30 September 2016 does not constitute the full statutory accounts for that period. The Annual Report and Financial Statements for the year ended 30 September 2016 have been filed with the Registrar of Companies. The Independent Auditors' Report on the Annual Report and Financial Statement for the year ended 30 September 2016 was unqualified, although did draw attention to matters by way of emphasis in relation to going concern, and did not contain a statement under 498(2) or 498(3) of the Companies Act 2006.

 

The directors prepare annual budgets and cash flow projections that extend beyond 12 months from the date of this report. These projections include the proceeds of future fundraising necessary within the next 12 months to meet the Company's and Group's planned discretionary project expenditures and to maintain the Company and Group as a going concern. Although the Company has been successful in raising finance in the past, there is no assurance that it will obtain adequate finance in the future. This represents a material uncertainty related to events or conditions which may cast significant doubt on the entity's ability to continue as a going concern and, therefore, that it may be unable to realise its assets and discharge its liabilities in the normal course of business. However, the directors have a reasonable expectation that they will secure additional funding when required to continue meeting corporate overheads and exploration costs for the foreseeable future and therefore believe that the going concern basis is appropriate for the preparation of the financial statements.

 

2. Loss per share

Loss per share has been calculated on the attributable loss for the period and the weighted average number of shares in issue during the period.

 

 

 

Six months

to 31 March

2017

Unaudited

Six months

to 31 March

2016

Unaudited

Twelve months

to 30 September

2016

Audited

 

 

 

 

Loss for the period (£)

(211,850)

(300,136)

(473,506)

Weighted average shares in issue (No.)

266,987,238

215,811,549

233,830,700

Basic and diluted loss per share (pence)

(0.08)

(0.14)

(0.20)

 

The loss attributable to ordinary shareholders and the weighted average number of ordinary shares used for the purpose of calculating diluted earnings per share are identical to those used to calculate the basic earnings per ordinary share. This is because the exercise of share warrants would have the effect of reducing the loss per ordinary share and is therefore not dilutive under the terms of IAS33.

 

 

 

3. Share capital

 

During the six months to 31 March 2017 the following share issues took place:

 

An issue of 132,720 1.0p Ordinary Shares at 1.025p per share to a director, in satisfaction of directors' fees, for a total consideration of £1,361 (31 January 2017).

 

4. Event after the Balance Sheet date

 

Capital subdivision

 

At a General Meeting on 13 April 2017 the shareholders approved the subdivision of the Company's ordinary share capital whereby each existing ordinary share with a nominal value of 1p was subdivided into 1 new ordinary share of 0.01p and 1 deferred share of 0.99p each.

 

The New Ordinary Shares have the same rights as those currently accruing to the Existing Ordinary Shares in issue under the Articles of Association of the Company, including those relating to voting and entitlement to dividends.

 

The Deferred Shares have no significant rights attached to them and carry no right to vote or participate in distribution of surplus assets and are not admitted to trading on the AIM market of the London Stock Exchange plc. The Deferred Shares effectively carry no value.

 

Placing

 

On 26 May 2017, an issue of 50,000,000 0.01p Ordinary Shares was made at a price of at 0.6p per share, by way of a placing, for a total gross consideration of £300,000.

 

5. Interim report

 

Copies of this interim report are available from Tertiary Minerals plc, Silk Point, Queens Avenue, Macclesfield, Cheshire SK10 2BB, United Kingdom.  It is also available on the Company's website at www.tertiaryminerals.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR AFMITMBBTBRR
Date   Source Headline
16th Apr 20242:00 pmRNSDrilling - Konkola West Copper Project, Zambia
9th Apr 20249:48 amRNSDrill Start - Konkola West Copper Project, Zambia
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20247:00 amRNSAgreement with Mwashia Resources
15th Feb 20242:31 pmRNSGrant of Warrants
15th Feb 20249:41 amRNSComplete Results of AGM
14th Feb 20242:19 pmRNSResult of AGM
6th Feb 20241:58 pmRNSUpdate: KoBold's New Mingomba Copper Discovery
18th Jan 202410:00 amRNSAnnual Report & Notice of Annual General Meeting
15th Jan 202410:15 amRNSAudited Results for Year Ended 30 September 2023
19th Dec 20239:20 amRNSCompany Presentation via Investor Meet Company
19th Dec 20237:00 amRNSEarn-In Agreement - Konkola West Project, Zambia
30th Nov 20237:00 amRNSKonkola West Copper Project, Zambia
6th Nov 20237:00 amRNSProject Update, Zambia
1st Nov 20237:00 amRNSPlacing to raise £150,000
16th Oct 20237:00 amRNSNew Soil Sampling Results - Mushima North, Zambia
5th Oct 20237:00 amRNSFirst Soil Sampling Results - Mushima North
25th Sep 20237:00 amRNSTerm Sheet for Agreement - Konkola West, Zambia
12th Sep 202310:04 amRNSProvisional Soil Sampling Results - Mukai Project
7th Sep 20237:00 amRNSGovernment Decision - Storuman Project, Sweden
6th Sep 20237:00 amRNSGovernment Decision - Storuman Project, Sweden
24th Aug 20237:00 amRNSUpdated Company Presentation
10th Aug 20237:00 amRNSExploration Update – Zambia
3rd Aug 20233:09 pmRNSUK Government Press Release Supports Zambia Growth
31st Jul 20237:00 amRNSForest Permits Received - Mukai & Mushima North
13th Jun 20237:00 amRNSNew Exploration Licence – Zambia
6th Jun 20237:00 amRNSExploration Update - Konkola West, Zambia
1st Jun 20237:00 amRNSProject Focus – Mushima North Project, Zambia
30th May 20232:40 pmRNSHALF-YEARLY REPORT 2023
17th May 20232:02 pmRNSExploration Update – Lubuila Copper Project
28th Apr 20237:00 amRNSAnalytical Results - Mushima North Copper Project
20th Apr 202310:00 amRNSExploration Update – Lubuila Copper Project
13th Apr 20232:45 pmRNSPlacing to raise £250,000
5th Apr 202310:30 amRNSProject Focus - Mukai Project, Zambia
9th Mar 202311:05 amRNSSecond Price Monitoring Extn
9th Mar 202311:00 amRNSPrice Monitoring Extension
17th Feb 20233:52 pmRNSGrant of Warrants
16th Feb 202311:39 amRNSResult of AGM
16th Feb 20237:00 amRNSChairman’s AGM Statement
14th Feb 20233:46 pmRNSHolding(s) in Company
3rd Feb 20238:20 amRNSPlacing to raise £300,000
18th Jan 20237:00 amRNSPositive Lab Results, Jacks Copper Project, Zambia
16th Jan 20237:00 amRNSEPB Approved Mushima North Copper Project, Zambia
12th Jan 20237:00 amRNSProject Focus - Konkola West, Zambia
22nd Dec 20227:00 amRNSAnnual Report & Notice of Annual General Meeting
12th Dec 20227:00 amRNSAudited Results for Year Ended 30 September 2022
25th Nov 20227:00 amRNSUpdate - Copper Projects, Zambia
8th Nov 20227:00 amRNSExploration Update - Jacks Copper Project, Zambia
4th Nov 202210:52 amRNSJacks Copper Project Zambia - JV Agreement
1st Nov 20227:00 amRNSExploration Update – Brunton Pass Project, Nevada

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.